|
Apr 2013
As of Apr 30, 2013
|
Jan 2013
As of Jan 31, 2013
|
Oct 2012
As of Oct 31, 2012
|
Apr 2012
As of Apr 30, 2012
|
Jan 2012
As of Jan 31, 2012
|
|
|---|---|---|---|---|---|
| Current Assets | |||||
| Cash | |||||
| Deferred Financing Expense | |||||
| Total Current Assets | |||||
| Other Assets | |||||
| Total Assets | |||||
| Current Liabilities | |||||
| Accounts Payable | |||||
| Accrued Interest | |||||
| Equity Obligations | |||||
| Current Portion of Notes Payable | |||||
| Convertible Notes Payable | |||||
| Derivative Liability | |||||
| Total Current Liabilities | |||||
| Total Liabilities | |||||
| Stockholders’ Deficit * | |||||
| Preferred Stock .001 Par Value, 5,000,000 shares authorized, 2,500,000 issued and outstanding, Series A preferred | |||||
| Common Stock .001 Par Value; 5,000,000,000 shares authorized; 44,372,932 and 4,432,451 shares issued and outstanding, respectively | |||||
| Additional paid in capital | |||||
| Deficit accumulated during the development stage | |||||
| Total Stockholders' Deficit | |||||
| Total Liabilities and Stockholders' Equity |
Loading...
